Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genix Bioventures is a venture studio and investment firm focused on the life sciences, specifically targeting longevity and age-related diseases. The company leverages its proprietary AI platform, Genix AI, to discover novel therapeutics and biomarkers by integrating computational biology with experimental validation. Genix Bioventures operates by founding and incubating specialized biotech companies, such as Genix Bio, which focus on developing small molecule interventions for neurodegeneration, metabolic health, and cellular senescence. The firm aims to bridge the gap between academic research and commercial drug development in the longevity space by accelerating the translation of aging science into clinical candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genix Bioventures.